Posts by rw-admin
3 “Magic Tricks” for Negotiating Salary in Your New Job
If you’re not working through an executive headhunter, you should be prepared to negotiate a compensation package that accurately reflects your value. However, many candidates avoid negotiations because they are uncomfortable or unaware of their market value. Don’t be discouraged by the awkward conversation, set yourself up for long-term success and satisfaction with these 3 tips for…
Read MoreFacial Reconstruction with No Scars
Scar-free facial reconstruction is now a reality. A team led by Daniel Borsuk, a doctor at Hôpital Maisonneuve-Rosemont and a professor at the University of Montreal, recently conducted the very first such procedure in the history of plastic surgery in Canada. The hospital is part of the CIUSS de l’Est-de-l’île-de-Montréal health network. In an eight-hour…
Read MoreHuman Limb Regeneration by 2030
On Veteran’s Day the University of Connecticut announced the launch of its new grand research challenge: regeneration of a human knee within 7 years, and an entire limb within 15 years. This major international research undertaking, called The HEAL Project, stands for Hartford Engineering a Limb. It is the brainchild of UConn Health’s Cato T.…
Read MoreNanostructured sunscreen ingredient may prevent medical implant MRSA infections
A common ingredient in sunscreen could be an effective antibacterial coating for medical implants such as joint replacements and pacemakers. Zinc oxide nanopyramids can disrupt methicillin-resistant Staphylococcus aureus (MRSA), reducing the film of bacteria growing on coated materials by over 95 percent. About one million implanted medical devices are infected each year. “It is extremely…
Read MoreSpectranetics Announces FDA Clearance of Turbo-Power(TM) Laser Atherectomy Catheter
COLORADO SPRINGS, Colo., Nov. 12, 2015 (GLOBE NEWSWIRE) — The Spectranetics Corporation (SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the Turbo-Power(TM) Laser Atherectomy Catheter, for the treatment of in-stent restenosis (ISR). Laser atherectomy is driving a new standard of care for in-stent restenosis treatment…
Read MoreBoston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences
MARLBOROUGH, Mass., Nov. 10, 2015 /PRNewswire/ — Boston Scientific (NYSE: BSX) has entered into a definitive agreement to acquire the interventional radiology portfolio of CeloNova Biosciences, a San Antonio-based developer of endovascular and interventional cardiology technologies. The structured agreement includes drug-eluting microspheres designed to be loaded with chemotherapy drugs for delivery to cancerous tumors, and…
Read MoreMeasure Blood Flow Through Skin Sensor
The Rogers Research Group at the University of Illinois at Urbana-Champaign have expanded on their flexible skin sensor technology to measure blood flow in vessels 1 to 2 millimeters under the skin. Current methods to measure blood flow in a clinical setting rely on optical imaging techniques that require patients to remain still for the…
Read MoreSherwin-Williams Launches Breakthrough Paint With the Power to Kill Bacteria
Sherwin-Williams announces the launch of Paint Shield™, the first EPA-registered microbicidal paint that continuously kills these difficult-to-treat, infection-causing bacteria after two hours of exposure on painted surfaces. By killing these infectious bacteria on painted surfaces, Paint Shield offers customers an important new tool to help prevent the spread of bacteria that can cause hospital-acquired infections…
Read MoreSmith & Nephew Shrugs Off Buyout Talk With 275M Blue Belt Technologies Acquisition
Smith & Nephew, British-based orthopedics giant, has expanded its foothold in the surgical robotics market with the $275 million acquisition of U.S.-based Blue Belt Technologies and its Navio robotics system. By combining its next-generation products with robotic technology, Smith & Nephew hopes to expand its market share and explore new surgical indications — all under…
Read MoreMedtronic Buys Lazarus Effect For 100 Million
Medtronic is acquiring private-held Lazarus Effect, developer of a mesh cover for stent retrievers of blood clots, for $100 million in cash. As part of the deal, Medtronic obtains the Lazarus Cover device, which will serve as an adjunct to Medtronic’s Solitaire stent retriever device, used to remove clots from acute ischemic stroke patients. A…
Read More